Although evidence supports safety of apixaban and rivaroxaban relative to warfarin, researchers had not directly compared their bleeding risk until last year.
Maribel Chahine, MS
Advertisement
Articles by Maribel Chahine, MS
Inflammation fuels residual ASCVD risk; survey reveals hs-CRP testing gaps, persistent angina, and new therapies for cardiovascular health.
Advertisement
Latest Updated Articles
Apixaban vs Rivaroxaban: A Clearer Choice for VTE?June 10th 2026
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
2
Bringing Bispecific Therapy Into the Outpatient Community Oncology Setting
3
Brain Imaging Study Links Long COVID to Dopamine Neuron Injury, Pointing to Repurposed Treatments
4
PPI, Antibiotic Exposure Associated With Attenuated Immunotherapy Benefit in Stage 3 NSCLC
5